ÂÜÀòÂÒÂ×

Eelo Gitz, PhD, has a diverse work experience in the field of biomedical sciences. They have held various positions at different organizations, showcasing their expertise and knowledge in their field.

Dr. Gitz started their career as an intern at the University Medical Center Groningen, where they conducted research on the effect of Fibroblast Growth Factor-2 overexpression in hematopoietic stem cells.

After completing their internship, Dr. Gitz moved on to the Rijksuniversiteit Groningen, where they conducted their final internship during their bachelor's degree in Biotechnology. The focus of their research was on the genetic structure and clonal architecture of the seagrass Zostera noltii in the Wadden Sea.

Dr. Gitz then joined UMC Utrecht as a PhD candidate, working on the role of glycoprotein Ibα in platelet storage and immune thrombocytopenia (ITP). After obtaining their PhD, they continued their research as a postdoctoral research fellow at UMC Utrecht, focusing on the effect of glycoprotein Ibα clustering on platelet binding to von Willebrand factor.

Following their time at UMC Utrecht, Dr. Gitz joined the University of Birmingham as a postdoctoral research fellow, specializing in the field of thrombosis and hemostasis. Their research focused on measuring platelet-specific microvesicles in patients with rheumatoid arthritis and other diseases, as well as studying the role of platelets in inflammation.

Dr. Gitz then transitioned to Sanquin, where they held multiple roles. They started as a research technician, working on the correlation between diabetes mellitus type 2 and thrombosis. They also conducted an internship during their master's degree in biomolecular sciences, focusing on the induction of insulin resistance in a megakaryocytic cell line. Later, Dr. Gitz became the Business Manager for MAT Kits & Services, overseeing the activities related to the Monocyte Activation Test (MAT) as an alternative to the rabbit pyrogen test on pharmaceutical products. Finally, they became the Acting Manager and Head of Product Development at Sanquin Reagents BV, where their responsibilities included the development, production, and marketing of blood grouping and immune reagents, kits, and devices.

Currently, Dr. Gitz is working as the Product Development Director at Eurotrol B.V. They are responsible for developing and producing Quality Control (QC) materials for In Vitro Diagnostic (IVD) medical devices.

Overall, Dr. Eelo Gitz's work experience demonstrates their expertise in the field of biomedical sciences, with a focus on thrombosis, hemostasis, and product development for medical devices.

Eelo Gitz, PhD, has a strong educational background in the field of science. In 2002, they began their undergraduate studies at Van Hall Larenstein University of Applied Sciences, where they pursued a Bachelor of Applied Science degree in Biotechnology. Eelo successfully completed their undergraduate studies in 2006.

Desiring to further deepen their knowledge and enhance their expertise in the field, Eelo went on to attend Utrecht University from 2007 to 2009. At Utrecht University, they pursued a Master of Science (MSc/Drs) degree in Biomedical Sciences. This program allowed him to gain in-depth insights into the field and further develop their research skills.

After successfully completing their MSc/Drs degree, Eelo Gitz continued their academic journey and pursued a PhD. However, specific information about their doctoral program is not provided in the given information. Nonetheless, with their solid educational foundation in Biomedical Sciences and Biotechnology, Eelo likely excelled in their doctoral studies and achieved their PhD in a related field.